RH: Form 10-Q for the period ended Oct 28, 2023
Filed with the SEC on Dec 7, 2023 and accepted by EDGAR at Dec 7, 2023, 22:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-10-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-30 to 2023-10-28 | $751.2m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2023-01-29 to 2023-10-28 | $2.29bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2023-07-30 to 2023-10-28 | $410.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-01-29 to 2023-10-28 | $1.22bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-07-30 to 2023-10-28 | $340.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-01-29 to 2023-10-28 | $1.07bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-07-30 to 2023-10-28 | $289.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-01-29 to 2023-10-28 | $766.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-07-30 to 2023-10-28 | $51.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-29 to 2023-10-28 | $301.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-07-30 to 2023-10-28 | $54.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-29 to 2023-10-28 | $138.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-30 to 2023-10-28 | −$9.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-29 to 2023-10-28 | $34.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-30 to 2023-10-28 | −$2.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-29 to 2023-10-28 | $116.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-30 to 2023-10-28 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-29 to 2023-10-28 | $5.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-30 to 2023-10-28 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-29 to 2023-10-28 | $5.68 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-30 to 2023-10-28 | 18,371,545 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-29 to 2023-10-28 | 22,207,813 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-29 to 2023-10-28 | $316.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-29 to 2023-10-28 | $131.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-01-29 to 2023-10-28 | $1.25bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-10-28 | $380.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-10-28 | $1.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-10-28 | $4.24bn | us-gaap:Assets |
| Current liabilities | At period end2023-10-28 | $935.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-10-28 | $4.57bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-10-28 | −$333.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-23-019631. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.